AbbVie
ABBV
#30
Rank
ยฃ237.14 B
Marketcap
ยฃ134.20
Share price
1.10%
Change (1 day)
21.37%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2024 (TTM): ยฃ5.63 Billion

According to AbbVie's latest financial reports the company's current earnings are ยฃ55.00 Billion. In 2023 the company made an earning of ยฃ4.94 Billion a decrease over its 2022 earnings that were of ยฃ10.66 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) ยฃ5.63 B14.02%
2023 ยฃ4.94 B-53.62%
2022 ยฃ10.66 B3.76%
2021 ยฃ10.27 B282.25%
2020 ยฃ2.68 B-59.67%
2019 ยฃ6.66 B62.13%
2018 ยฃ4.11 B-32.74%
2017 ยฃ6.11 B-1.99%
2016 ยฃ6.23 B18.65%
2015 ยฃ5.25 B180.5%
2014 ยฃ1.87 B-55.57%
2013 ยฃ4.21 B-6.86%
2012 ยฃ4.52 B56.05%
2011 ยฃ2.90 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ0.96 Billion-117.15%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ5.45 Billion-197.37%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ8.03 B 43.65%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.70 B-33.78%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.21 B-78.23%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.03 B-81.41%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.30 B-40.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ7.43 B 33.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ0.51 B-90.71%๐Ÿ‡บ๐Ÿ‡ธ USA